Asia Pacific Venous Diseases Treatment Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2023 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
Dollars américains 2,118.93 |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché du traitement des maladies veineuses en Asie-Pacifique, par type de produit (injection de sclérothérapie, dispositifs d'ablation, produits de fermeture veineuse, stents veineux, médicaments et autres), type de maladie (thrombose veineuse profonde (TVP), insuffisance veineuse chronique (IVC), embolie pulmonaire, thrombophlébite superficielle, varices et autres), type de traitement (sclérothérapie, thérapie par ablation par radiofréquence, traitement au laser, phlébectomie ambulatoire, ligature et décapage des veines, angioplastie ou stenting, chirurgies, thérapie par compression, médicaments veinoactifs, filtre de veine cave et autres thérapies), utilisateur final (hôpitaux, cliniques, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, ventes au détail et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et perspectives du marché du traitement des maladies veineuses en Asie-Pacifique
Les maladies veineuses incluent des caillots sanguins dans les jambes, les bras, le cerveau, les poumons ou les organes internes tels que les reins, la rate, le foie, la thrombose veineuse profonde, l'insuffisance veineuse chronique, les varices et les veines, ainsi que les ulcères dans les veines. Le traitement de cette maladie comprend une pharmacothérapie, l'ablation endogène au laser ou l'ablation par radiofréquence (RFA), la sclérothérapie et la chirurgie.
Data Bridge Market Research analyse que le marché du traitement des maladies veineuses en Asie-Pacifique devrait atteindre la valeur de 2 118,93 millions USD d'ici 2030, à un TCAC de 8,4 % au cours de la période de prévision. Ce rapport de marché couvre également en profondeur l'analyse des prix, l'analyse des brevets et les avancées technologiques.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable jusqu'au 2020-1015) |
|
Unités quantitatives |
Chiffre d'affaires en millions, prix en USD |
|
Segments couverts |
Par type de produit (injection de sclérothérapie, dispositifs d'ablation, produits de fermeture veineuse, stents veineux, médicaments et autres), type de maladie (thrombose veineuse profonde (TVP), insuffisance veineuse chronique (IVC), embolie pulmonaire, thrombophlébite superficielle, varices et autres), type de traitement (sclérothérapie, thérapie d'ablation par radiofréquence, traitement au laser, phlébectomie ambulatoire, ligature et stripping des veines, angioplastie ou stenting, chirurgies, thérapie par compression, médicaments veinoactifs, filtre de veine cave et autres thérapies), utilisateur final (hôpitaux, cliniques, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, vente au détail et autres) |
|
Pays couverts |
Chine, Inde, Japon, Indonésie, Philippines, Thaïlande, Australie, Malaisie, Corée du Sud, Singapour, Reste de l'Asie-Pacifique |
|
Acteurs du marché couverts |
Français Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex incorporated, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips NV, Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems et Bolitec Laser entre autres. |
Asia-Pacific Venous Diseases Treatment Market Definition
Heart attacks, and strokes are usually acute events, and are primarily caused by a blockage that blocks blood flow to the heart or brain. The most common cause is the build-up of fatty deposits in the lining of the blood vessels that supply the heart or brain. A stroke can be caused by bleeding or blood clots in a blood vessel in the brain.
Technological advancements in vascular stents, increase in demand for minimally invasive procedures, and rise in geriatric population are driving the Asia-Pacific market. Moreover, the companies are expanding their product portfolio to offer the best services for venous diseases treatment. Medical devices such as ablation devices are used in minimally invasive procedures to remove or excise abnormal body tissues for therapeutic purposes. These systems use the heat generated by radio frequency, energy, extreme cold, or a laser to cause small burns. Rise in adoption of robotic technologies for product application expansion, and integration of cutting-edge technologies in ablation devices to improve patient safety, and procedural efficiency are expected to drive the market.
Asia-Pacific Venous Diseases Treatment Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Rising incidences of venous diseases
Venous diseases are the conditions that damage veins in body. Damaged blood vessel walls prevent the circulatory system from working, causing blood to pool and reflux (backwards) when the muscles relax. This causes abnormally high pressure to build up in the veins. This build-up causes veins to tighten and twist, increased swelling, increased valve incompetence, slow blood flow, and possible blood clots. Finally, this condition can lead to various diseases known as venous diseases.
Due to various risk factors such as ageing, obesity, high blood pressure (hypertension) or family history of venous disease, patients with venous diseases are rising globally and becoming a significant socio-economic issue. Thus the rising number of patients with venous diseases increases the demand for venous diseases treatment which act as a driver in the Asia-Pacific venous diseases treatment market.
- Rapid changes in lifestyle leads to obesity resulting in venous diseases
Lifestyle changes such as smoking, unhealthy diet and physical inactivity lead to the development of chronic diseases, especially heart disease, stroke, diabetes, obesity and metabolic syndrome that can eventually result in venous diseases.
Physical activity is essential and many conditions are a direct result of a sedentary lifestyle. Sedentary lifestyle may result in gain weight, tire easily and have unexplained aches and pains that develop chronic condition, including cardiovascular and venous disease, ranging from moderate, severe or even life-threatening.
According to the article of ScienceDirect, venous disease was more clinically severe in the obese limbs than non-obese group. Thus due to increase in adoption of unhealthy lifestyle there is rapid increase in obese population with venous diseases rising. Thus the rapid changes in lifestyle leads to obesity resulting in venous diseases which increases the demand for venous diseases treatment and act as a driver in the Asia-Pacific venous diseases treatment market.
Restraint
- Lack of skilled and certified professionals
The requirement of skilled and certified professionals is a big restraint for venous diseases treatment market. The demand for venous disease treatment is increased due to increasing cases of venous diseases in the Europe but the less number of skilled professionals present in the healthcare center is hampering the growth of the market.
Chronic venous disease (CVD) is often overlooked by healthcare professionals because they do not understand the extent and impact of the problem, and the different manifestations of primary and secondary venous disease are not fully recognized. The importance of cardiovascular diseases is related to the number of patients and to the socio-economic effects of its more serious manifestations.
Opportunity
- Rising awareness towards venous disorders
Both medicinal procedures and lifestyle changes can be used to treat vein problems. Your veins can benefit from medication, exercise, and compression stockings, but occasionally vein problems necessitate more thorough therapy to restore the health and performance of your veins. The course of treatment is determined by the kind and severity of the venous disease. Patients with vascular disorders have increased dramatically over the past few decades, with diabetes serving as the most flagrant risk factor. Unlike other health problems, vascular disorders and vascular surgery are unknown to approximately 80% of the population. People's attitudes and behaviours about particular illnesses can change significantly as a result of increased health awareness.
There are several awareness programs are conducted by various societies, government institutes and others. These initiatives taken by them will increase awareness among people regarding their health and take early diagnosis for better cure and precaution. For this reason, rising awareness towards venous disorders are expected to act as an opportunity for growing the demand of the Asia-Pacific venous diseases treatment market.
Challenge
- High cost associated with venous disease treatment
More than 25 million persons in the United States alone suffer from chronic venous insufficiency (CVI), with more than 6 million having advanced venous illness. The US healthcare system is heavily burdened financially as a result of the high incidence of CVI and rising healthcare costs. Numerous widespread health issues are caused by poor venous circulation. Leg pain, edoema, and heaviness are some of the early signs of chronic venous disease (CVD), and they can be present all day long or become more pronounced in the evening. Patients frequently seek out initial therapy for symptoms that might occur with or without varicose veins, as well as for cosmetic varicose vein removal. The two main risk factors for CVD are advancing age and high body mass.
Post-COVID-19 Impact on Asia-Pacific Venous Diseases Treatment Market
The pandemic has had adverse impacts on the manufacturers as well as users. As varicose veins procedures are non-urgent, the volume of procedures declined drastically. Reduction in the surgeries or procedures for the treatment of varicose veins due to traveling restrictions also impacted the sales of the manufacturers.
Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launch and strategic partnerships to improve the technology and test results involved in the pet food flavors and ingredients market.
Recent Developments
- In July 2022, Smith+Nephew, the Asia-Pacific medical technology company has launches Clinical Support App to help reduce practice variation in wound care. The WOUND COMPASS Clinical Support App is a comprehensive digital support tool for health care professionals that aids wound assessment and decision-making to help reduce practice variation. This has helped the company to attract the healthcare customers and expand product portfolio
- In April 2022, Carl Zeiss Meditec has announced the acquisition of two manufacturers of surgical instruments (Kogent Surgical, LLC and Katalyst Surgical, LLC) to further strengthen its positioning as a solution provider. This has helped the company to expand their business
Asia-Pacific Venous Diseases Treatment Market Scope
Asia-Pacific venous diseases treatment market is segmented into product type, disease type, treatment type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE
- ABLATION DEVICES
- VENOUS STENTS
- VENOUS CLOSURE PRODUCTS
- SCLEROTHERAPY INJECTION
- MEDICATIONS
- OTHERS
On the basis of product type, the Asia-Pacific venous diseases treatment market is segmented into ablation devices, venous stents, venous closure products, sclerotherapy injection, medications, and others.
ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE
- DEEP VEIN THROMBOSIS (DVT)
- CHRONIC VENOUS INSUFFICIENCY (CVI)
- PULMONARY EMBOLISM
- SUPERFICIAL THROMBOPHLEBITIS
- VARICOSE VEINS
- OTHERS
On the basis of disease type, the Asia-Pacific venous diseases treatment market is segmented into deep vein thrombosis (DVT), chronic venous insufficiency (CVI), pulmonary embolism, superficial thrombophlebitis, varicose veins, and others.
ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE
- COMPRESSION THERAPY
- VENO ACTIVE MEDICATION
- SURGERIES
- SCLEROTHERAPY
- ANGIOPLASTY OR STENTING
- VEIN LIGATION AND STRIPPING
- VENA CAVA FILTER
- AMBULATORY PHLEBECTOMY
- RADIOFREQUENCY ABLATION THERAPY
- LASER TREATMENT
- OTHERS THERAPIES
On the basis of treatment type, the Asia-Pacific venous diseases treatment market is segmented into compression therapy, veno active medication, surgeries, scelrotherapy, angioplasty or stenting, vein legation, and stripping, vena cava filter, ambulatory phlebectomy, radiofrequency ablation therapy, laser treatment, and other therapies.
ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY END USER
- HOSPITALS
- CLINICS
- AMBULATORY SURGICAL CENTERS
- OTHERS
On the basis of end user, the Asia-Pacific venous diseases treatment market is segmented into hospitals, clinics, ambulatory surgical centers, and others.
ASIA-PACIFIC VENOUS DISEASES TREATMENTS MARKET, BY DISTRIBUTION CHANNEL
- DIRECT TENDER
- RETAIL SALES
- OTHERS
On the basis of distribution channel, the Asia-Pacific venous diseases treatment market is segmented into direct tender, retail sales, and others.
Asia-Pacific Venous Diseases Treatment Market Regional Analysis/Insights
Asia-Pacific venous diseases treatment market is analyzed and market size information is provided product type, disease type, treatment type, end user, and distribution channel.
China is dominating Asia-Pacific due to rise in prevelance venous disease among the population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Venous Diseases Treatment Market Share Analysis
Le paysage concurrentiel du marché du traitement des maladies veineuses en Asie-Pacifique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements en R&D, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et la portée du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché du traitement des maladies veineuses en Asie-Pacifique.
Certains des principaux acteurs opérant sur le marché du traitement des maladies veineuses en Asie-Pacifique sont Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex incorporated, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips NV, Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems, Bolitec Laser entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 INSTRUMENT BASED LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, INDUSTRY INSIGHTS
6 EPIDEMIOLOGY
7 REGULATORY FRAMEWORK
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISING INCIDENCES OF VENOUS DISEASES
8.1.2 RAPID CHANGES IN LIFESTYLE LEAD TO OBESITY RESULTING IN VENOUS DISEASES
8.1.3 INCREASE IN THE GERIATRIC POPULATION
8.1.4 TECHNOLOGICALLY ADVANCEMENT IN THE TREATMENT OF VENOUS DISEASES
8.2 RESTRAINTS
8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
8.2.2 INADEQUATE REIMBURSEMENT COVERAGE
8.3 OPPORTUNITIES
8.3.1 RISING AWARENESS TOWARDS VENOUS DISORDERS
8.3.2 NEED FOR PROPER DIAGNOSIS AND TREATMENT OF VENOUS DISEASES
8.3.3 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
8.3.4 OCCUPATIONAL LIFESTYLE INCREASES THE NEED FOR VENOUS DISEASE TREATMENT
8.4 CHALLENGES
8.4.1 HIGH COST ASSOCIATED WITH VENOUS DISEASE TREATMENT
8.4.2 SIDE EFFECTS AND RISK ASSOCIATED WITH DIFFERENT TREATMENT MODES
9 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 SCLEROTHERAPY INJECTION
9.2.1 SCLEROTHERAPY, BY TYPE
9.2.1.1 INTRAVENOUS
9.2.1.2 INTRADERMAL
9.2.1.3 SUBCUTANEOUS
9.2.2 SUBCUTANEOUS, BY APPLICATION
9.2.2.1 MALFORMED LYMPHED VESSELS
9.2.2.2 HEMORRHOIDS
9.2.2.3 HYDROCELES
9.2.2.4 OTHERS
9.3 ABLATION DEVICES
9.3.1 THERMAL ABLATION
9.3.1.1 RADIOFREQUENCY
9.3.1.1.1 CATHETER MANIPULATION SYSTEMS
9.3.1.1.2 TEMPERATURE CONTROLLED
9.3.1.1.3 FLUID COOLED
9.3.1.2 LIGHT
9.3.1.2.1 EXCIMER LASERS
9.3.1.2.2 COLD LASERS
9.3.1.3 ULTRASOUND
9.3.1.3.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)
9.3.1.3.2 SHOCK WAVE LITHOTRIPSY
9.3.1.3.3 MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND (MRI-FUS)
9.3.1.3.4 ULTRASONIC SURGICAL SYSTEMS
9.3.1.4 RADIATION
9.3.1.4.1 STEREOTACTIC BODY RADIATION THERAPY
9.3.1.4.2 INTENSITY-MODULATED RADIATION THERAPY
9.3.1.4.3 STEREOTACTIC RADIOTHERAPY & RADIOSURGERY
9.3.1.4.4 IMAGE GUIDED RADIATION THERAPY
9.3.1.4.5 INTRAVASCULAR BRACHYTHERAPY
9.3.1.4.6 PROTON BEAM THERAPY
9.3.1.5 ELECTRICAL
9.3.1.5.1 ELECTRICAL ABLATORS
9.3.1.5.2 ELECTRONIC BRACHYTHERAPY
9.3.1.6 MICROWAVE
9.3.1.7 HYDROTHERMAL
9.3.2 NON-THERMAL ABLATION
9.3.2.1 CRYOABLATION
9.3.2.1.1 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
9.3.2.1.2 CRYOGEN SPRAY PROBE
9.3.2.1.3 TISSUE CONTACT PROBE
9.3.2.2 HYDROMECHANICAL ABLATION
9.4 VENOUS CLOSURE PRODUCTS
9.4.1 VENOUS CLOSURE PRODUCTS, BY PROCEDURE
9.4.1.1 INTERVENTIONAL CARDIOLOGY
9.4.1.2 INTERVENTIONAL RADIOLOGY
9.4.2 VENOUS CLOSURE PRODUCTS, BY TECHNOLOGY
9.4.2.1 FEMORAL ACCESS TECHNIQUE
9.4.2.2 RADIAL ACCESS TECHNIQUE
9.5 VENOUS STENTS
9.5.1 VENOUS STENTS, BY TECHNOLOGY
9.5.1.1 WALLSTENT TECHNOLOGY
9.5.1.2 ILIAC VEIN STENT TECHNOLOGY
9.5.2 VENOUS STENTS, BY APPLICATION
9.5.2.1 LEG
9.5.2.2 CHEST
9.5.2.3 ABDOMEN
9.5.2.4 OTHERS
9.6 MEDICATION
9.7 OTHERS
10 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE
10.1 OVERVIEW
10.2 VARICOSE VEINS
10.3 DEEP VEIN THROMBOSIS (DVT)
10.4 PULMONARY EMBOLISM
10.5 CHRONIC VENOUS INSUFFICIENCY (CVI)
10.6 SUPERFICIAL THROMBOPHLEBITIS
10.7 OTHERS
11 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE
11.1 OVERVIEW
11.2 SCLEROTHERAPY
11.3 RADIOFREQUENCY ABLATION THERAPY
11.4 LASER TREATMENT
11.5 AMBULATORY PHLEBECTOMY
11.6 VEIN LIGATION AND STRIPPING
11.7 ANGIOPLASTY OR STENTING
11.8 SURGERIES
11.9 COMPRESSION THERAPY
11.1 VEINACTIVE MEDICATION
11.11 VENA CAVA FILTER
11.12 OTHER THERAPIES
12 ASIA-PACIFIC VENOUS TREATMENT DISEASES MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 OTHERS
13 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 JAPAN
14.1.3 INDIA
14.1.4 AUSTRALIA
14.1.5 INDONESIA
14.1.6 SINGAPORE
14.1.7 MALAYSIA
14.1.8 PHILIPPINES
14.1.9 SOUTH KOREA
14.1.10 THAILAND
14.1.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 MEDTRONIC
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 BOSTON SCIENTIFIC CORPORATION
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 VARIAN MEDICAL SYSTEMS, INC.
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 STRYKER
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 KONINKLIJKE PHILIPS N.V.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 ABBOTT
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 ALMA LASERS
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANGIODYNAMICS
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 B.BRAUN MELSUNGEN AG
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 BAYLIS MEDICAL COMPANY, INC
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 BD
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 CANDELA MEDICAL
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 CARL ZEISS MEDITEC AG
17.13.1 COMPANYSNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 COOK
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 IMRICOR
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.16 OLYMPUS CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOILIO
17.16.4 RECENT DEVELOPMENT
17.17 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 PLUSMEDICA.DE
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 SCITECH
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 SMITH + NEPHEW
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENT
17.21 SONABLATE
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 THERACLION
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 TELEFLEX INCORPORATED
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 TERUMO CORPORATION
17.24.1 COMPANY SNAPSHOT
17.24.2 REVENUE ANALYSIS
17.24.3 PRODUCT PORTFOLIO
17.24.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
Liste des tableaux
TABLE 1 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 5 ASIA-PACIFIC ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 ASIA-PACIFIC ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 ASIA-PACIFIC THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 ASIA-PACIFIC RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 ASIA-PACIFIC LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 ASIA-PACIFIC ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA-PACIFIC RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 ASIA-PACIFIC ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 ASIA-PACIFIC NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 ASIA-PACIFIC CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 17 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 18 ASIA-PACIFIC VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 ASIA-PACIFIC VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 20 ASIA-PACIFIC ILIAC VEIN STENT TECHNOLOGY IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 21 ASIA-PACIFIC MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 ASIA-PACIFIC OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 24 ASIA-PACIFIC VARICOSE VEINS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 ASIA-PACIFIC DEEP VEIN THROMBOSIS (DVT) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 ASIA-PACIFIC PULMONARY EMBOLISM IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 ASIA-PACIFIC CHRONIC VENOUS INSUFFICIENCY (CVI) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 ASIA-PACIFIC SUPERFICIAL THROMBOPHLEBITIS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC SCELEROTHERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC RADIOFREQUENCY ABLATION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 ASIA-PACIFIC LASER TREATMENT IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 ASIA-PACIFIC AMBULATORY PHELEBECTOMY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 ASIA-PACIFIC VEIN LIGATION AND STRIPPING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 ASIA-PACIFIC ANGIOPLASTY OR STENTING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 ASIA-PACIFIC SURGERIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 ASIA-PACIFIC COMPRESSION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 ASIA-PACIFIC VEINACTIVE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 ASIA-PACIFIC VENA CAVA FILTER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 ASIA-PACIFIC OTHER THERAPIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 43 ASIA-PACIFIC HOSPITALS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 ASIA-PACIFIC CLINICS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 ASIA-PACIFIC OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 ASIA-PACIFIC DIRECT TENDER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 ASIA-PACIFIC RETAIL SALES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 ASIA-PACIFIC OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 ASIA-PACIFIC VENOUS DISEASE TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 52 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 53 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 ASIA-PACIFIC ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 ASIA-PACIFIC THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 ASIA-PACIFIC RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 ASIA-PACIFIC LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 59 ASIA-PACIFIC ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 60 ASIA-PACIFIC RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 ASIA-PACIFIC ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 ASIA-PACIFIC NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 ASIA-PACIFIC CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 65 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 66 ASIA-PACIFIC VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 67 ASIA-PACIFIC VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 68 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 69 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 70 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 72 CHINA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 73 CHINA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 74 CHINA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 CHINA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 CHINA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 77 CHINA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 78 CHINA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 CHINA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 CHINA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 CHINA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 CHINA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 CHINA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 CHINA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 85 CHINA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 86 CHINA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 87 CHINA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 CHINA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 89 CHINA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 90 CHINA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 CHINA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 JAPAN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 JAPAN SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 94 JAPAN SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 JAPAN ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 JAPAN THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 JAPAN RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 JAPAN LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 JAPAN ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 JAPAN RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 JAPAN ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 JAPAN NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 103 JAPAN CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 104 JAPAN VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 105 JAPAN VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 106 JAPAN VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 107 JAPAN VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 JAPAN VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 109 JAPAN VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 110 JAPAN VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 JAPAN VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 112 INDIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 INDIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 INDIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 115 INDIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 INDIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 INDIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 INDIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 INDIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 120 INDIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 INDIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 INDIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 INDIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 INDIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 125 INDIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 126 INDIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 127 INDIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 128 INDIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 129 INDIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 130 INDIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 INDIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 AUSTRALIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 134 AUSTRALIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 135 AUSTRALIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 AUSTRALIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 AUSTRALIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 AUSTRALIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 AUSTRALIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 AUSTRALIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 141 AUSTRALIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 AUSTRALIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 143 AUSTRALIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 AUSTRALIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 145 AUSTRALIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 146 AUSTRALIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 147 AUSTRALIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 148 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 149 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 150 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 152 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 INDONESIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 INDONESIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 155 INDONESIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 156 INDONESIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 157 INDONESIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 INDONESIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 INDONESIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 INDONESIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 INDONESIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 INDONESIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 INDONESIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 INDONESIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 165 INDONESIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 166 INDONESIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 167 INDONESIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 168 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 169 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 170 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 171 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 172 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 173 SINGAPORE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 SINGAPORE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 SINGAPORE ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 176 SINGAPORE THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 177 SINGAPORE RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 SINGAPORE LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 179 SINGAPORE ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 180 SINGAPORE RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 SINGAPORE ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 SINGAPORE NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 SINGAPORE CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 SINGAPORE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 185 SINGAPORE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 186 SINGAPORE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 187 SINGAPORE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 188 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 189 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 190 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 191 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 192 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 193 MALAYSIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 194 MALAYSIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 195 MALAYSIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 MALAYSIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 MALAYSIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 MALAYSIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 MALAYSIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 200 MALAYSIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 MALAYSIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 MALAYSIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 203 MALAYSIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 MALAYSIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 205 MALAYSIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 206 MALAYSIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 207 MALAYSIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 208 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 209 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 210 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 211 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 212 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 PHILIPPINES SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 214 PHILIPPINES SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 PHILIPPINES ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 216 PHILIPPINES THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 PHILIPPINES RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 PHILIPPINES LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 219 PHILIPPINES ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 PHILIPPINES RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 PHILIPPINES ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 222 PHILIPPINES NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 223 PHILIPPINES CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 224 PHILIPPINES VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 225 PHILIPPINES VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 226 PHILIPPINES VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 227 PHILIPPINES VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 229 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 230 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 231 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 232 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 233 SOUTH KOREA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 234 SOUTH KOREA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 235 SOUTH KOREA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 SOUTH KOREA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 237 SOUTH KOREA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 SOUTH KOREA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 239 SOUTH KOREA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 SOUTH KOREA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 241 SOUTH KOREA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 SOUTH KOREA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 SOUTH KOREA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 244 SOUTH KOREA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 245 SOUTH KOREA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 246 SOUTH KOREA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 247 SOUTH KOREA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 249 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 250 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 251 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 252 THAILAND VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 253 THAILAND SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 254 THAILAND SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 255 THAILAND ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 THAILAND THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 257 THAILAND RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 258 THAILAND LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 THAILAND ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 260 THAILAND RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 261 THAILAND ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 THAILAND NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 THAILAND CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 264 THAILAND VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 265 THAILAND VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 266 THAILAND VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 267 THAILAND VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 268 THAILAND VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 269 THAILAND VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 270 THAILAND VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 271 THAILAND VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 272 REST OF ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: SEGMENTATION
FIGURE 11 GROWING AWARENESS ABOUT VENOUS DISEASES TREATMENTS AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET FROM 2023 TO 2030
FIGURE 12 THE ABLATION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET
FIGURE 14 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2022
FIGURE 15 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2022
FIGURE 19 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2023-2030 (USD MILLION)
FIGURE 20 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, CAGR (2023-2030)
FIGURE 21 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2022
FIGURE 23 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)
FIGURE 24 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2023-2030)
FIGURE 25 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY END USER, 2022
FIGURE 27 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022)
FIGURE 35 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022)
FIGURE 36 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030)
FIGURE 39 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
